<ichicsr lang="en"><ichicsrmessageheader>
  <messagetype>ICSR</messagetype>
  <messageformatversion>2.1</messageformatversion>
  <messageformatrelease>1.0</messageformatrelease>
  <messagenumb>2013-07</messagenumb>
  <messagesenderidentifier>FDA CDER</messagesenderidentifier>
  <messagereceiveridentifier>Public Use</messagereceiveridentifier>
  <messagedateformat>204</messagedateformat>
  <messagedate>20130731090721</messagedate>
</ichicsrmessageheader>
<safetyreport>
  <safetyreportversion>2</safetyreportversion>
  <safetyreportid>7795712</safetyreportid>
  <primarysourcecountry>US</primarysourcecountry>
  <transmissiondateformat>102</transmissiondateformat>
  <transmissiondate>20130627</transmissiondate>
  <reporttype>1</reporttype>
  <serious>1</serious>
  <seriousnessother>1</seriousnessother>
  <receivedateformat>102</receivedateformat>
  <receivedate>20110118</receivedate>
  <receiptdateformat>102</receiptdateformat>
  <receiptdate>20121003</receiptdate>
  <fulfillexpeditecriteria>1</fulfillexpeditecriteria>
  <companynumb>2011MA000142</companynumb>
  <duplicate>1</duplicate>
  <reportduplicate>
    <duplicatesource>ACTAVIS ELIZABETH</duplicatesource>
    <duplicatenumb>2011MA000142</duplicatenumb>
  </reportduplicate>
  <primarysource>
    <reportercountry>US</reportercountry>
    <qualification>4</qualification>
  </primarysource>
  <sender>
    <sendertype>2</sendertype>
    <senderorganization>FDA-Public Use </senderorganization>
  </sender>
  <receiver>
    <receivertype>6</receivertype>
    <receiverorganization>FDA</receiverorganization>
  </receiver>
  <patient>
    <patientweight>87.09</patientweight>
    <patientsex>1</patientsex>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Tardive dyskinesia</reactionmeddrapt>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Akathisia</reactionmeddrapt>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Extrapyramidal disorder</reactionmeddrapt>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Economic problem</reactionmeddrapt>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Emotional disorder</reactionmeddrapt>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Depression</reactionmeddrapt>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Nightmare</reactionmeddrapt>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Psychotic disorder</reactionmeddrapt>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Muscle twitching</reactionmeddrapt>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Hypersomnia</reactionmeddrapt>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Memory impairment</reactionmeddrapt>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Anxiety</reactionmeddrapt>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Suicidal ideation</reactionmeddrapt>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Fear</reactionmeddrapt>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Aphagia</reactionmeddrapt>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Social avoidant behaviour</reactionmeddrapt>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Feeling abnormal</reactionmeddrapt>
    </reaction>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>METOCLOPRAMIDE</medicinalproduct>
      <drugauthorizationnumb>70581</drugauthorizationnumb>
      <drugstructuredosagenumb>10</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugseparatedosagenumb>1</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>2</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>804</drugintervaldosagedefinition>
      <drugdosagetext>PO</drugdosagetext>
      <drugadministrationroute>048</drugadministrationroute>
      <drugindication>GERD</drugindication>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20021211</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20090628</drugenddate>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>METOCLOPRAMIDE</medicinalproduct>
      <drugauthorizationnumb>70581</drugauthorizationnumb>
      <drugstructuredosagenumb>10</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugseparatedosagenumb>1</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>2</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>804</drugintervaldosagedefinition>
      <drugdosagetext>PO</drugdosagetext>
      <drugadministrationroute>048</drugadministrationroute>
      <drugindication> OESOPHAGITIS</drugindication>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20021211</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20090628</drugenddate>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>ACIPHEX</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>ALPRAZOLAM</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>BUSPIRONE</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>CIALIS</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>CIPROFLOXIN</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>CRESTOR</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>GABAPENTIN</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>HYDROCODONE/APAP</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>LEVITRA</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>LIPITOR</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>LISINOPRIL</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>NEXIUM</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>OMEPRAZOLE</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>PRAZOSIN</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>PREVACID</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>SEROQUEL</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>SERTRALINE</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>SMZ/TMP</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>WELLBUTRIN</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>ZOCOR</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>ZOLPIDEM</medicinalproduct>
    </drug>
  </patient>
</safetyreport>
<safetyreport>
  <safetyreportversion>5</safetyreportversion>
  <safetyreportid>7795970</safetyreportid>
  <primarysourcecountry>JP</primarysourcecountry>
  <occurcountry>JP</occurcountry>
  <transmissiondateformat>102</transmissiondateformat>
  <transmissiondate>20130627</transmissiondate>
  <reporttype>2</reporttype>
  <serious>1</serious>
  <seriousnesshospitalization>1</seriousnesshospitalization>
  <seriousnessother>1</seriousnessother>
  <receivedateformat>102</receivedateformat>
  <receivedate>20110202</receivedate>
  <receiptdateformat>102</receiptdateformat>
  <receiptdate>20121005</receiptdate>
  <fulfillexpeditecriteria>1</fulfillexpeditecriteria>
  <companynumb>JP-ROCHE-756131</companynumb>
  <duplicate>1</duplicate>
  <reportduplicate>
    <duplicatesource>ROCHE</duplicatesource>
    <duplicatenumb>JP-ROCHE-756131</duplicatenumb>
  </reportduplicate>
  <primarysource>
    <reportercountry>JP</reportercountry>
    <qualification>1</qualification>
  </primarysource>
  <sender>
    <sendertype>2</sendertype>
    <senderorganization>FDA-Public Use </senderorganization>
  </sender>
  <receiver>
    <receivertype>6</receivertype>
    <receiverorganization>FDA</receiverorganization>
  </receiver>
  <patient>
    <patientonsetage>72.26</patientonsetage>
    <patientsex>1</patientsex>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Angina pectoris</reactionmeddrapt>
      <reactionoutcome>1</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Prostate cancer</reactionmeddrapt>
      <reactionoutcome>3</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Coronary artery stenosis</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Arthritis</reactionmeddrapt>
      <reactionoutcome>1</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Chest pain</reactionmeddrapt>
      <reactionoutcome>2</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Chest pain</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Chest pain</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Blood cholesterol increased</reactionmeddrapt>
      <reactionoutcome>1</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Eczema</reactionmeddrapt>
      <reactionoutcome>2</reactionoutcome>
    </reaction>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>430</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugindication>RHEUMATOID ARTHRITIS</drugindication>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20090114</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20090114</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>430</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20090212</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20090212</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>430</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20090311</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20090311</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>430</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20090408</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20090408</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>430</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20090507</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20090507</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>430</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20090603</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20090603</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>430</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20090701</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20090701</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>430</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20090729</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20100729</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>430</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20090826</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20100826</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>430</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20090924</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20100924</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>430</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20091021</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20101021</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>430</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20091118</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20101118</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>430</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20091216</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20101216</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>410</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20100113</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20110113</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>400</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20100210</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20100210</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>400</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20100310</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20100310</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>400</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20100331</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20100331</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>400</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20100428</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20100428</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>400</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20100526</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20100526</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>400</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20100623</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20100623</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>400</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20100721</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20100721</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>400</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20100818</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20100818</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>390</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20100915</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20100915</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>390</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20101013</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20101013</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>400</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20101110</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20101110</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>400</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20101208</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20101208</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>400</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20110105</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20110105</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ROACTEMRA</medicinalproduct>
      <drugauthorizationnumb>125276</drugauthorizationnumb>
      <drugstructuredosagenumb>380</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>041</drugadministrationroute>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>PREDNISOLONE</medicinalproduct>
      <drugstructuredosagenumb>4</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugseparatedosagenumb>1</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>804</drugintervaldosagedefinition>
      <drugdosageform>Tablet</drugdosageform>
      <drugadministrationroute>048</drugadministrationroute>
      <drugindication>RHEUMATOID ARTHRITIS</drugindication>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>PREDNISOLONE</medicinalproduct>
      <drugstructuredosagenumb>5</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugseparatedosagenumb>1</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>804</drugintervaldosagedefinition>
      <drugdosageform>Tablet</drugdosageform>
      <drugadministrationroute>048</drugadministrationroute>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20090311</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20090924</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>PREDNISOLONE</medicinalproduct>
      <drugstructuredosagenumb>4</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugseparatedosagenumb>1</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>804</drugintervaldosagedefinition>
      <drugdosageform>Tablet</drugdosageform>
      <drugadministrationroute>048</drugadministrationroute>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>RHEUMATREX</medicinalproduct>
      <drugstructuredosagenumb>6</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugseparatedosagenumb>1</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>803</drugintervaldosagedefinition>
      <drugdosageform>Capsule</drugdosageform>
      <drugadministrationroute>048</drugadministrationroute>
      <drugindication>RHEUMATOID ARTHRITIS</drugindication>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20090730</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20100113</drugenddate>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>CYTOTEC</medicinalproduct>
      <drugstructuredosagenumb>400</drugstructuredosagenumb>
      <drugstructuredosageunit>004</drugstructuredosageunit>
      <drugseparatedosagenumb>1</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>804</drugintervaldosagedefinition>
      <drugdosageform>Tablet</drugdosageform>
      <drugadministrationroute>048</drugadministrationroute>
      <drugindication>GASTRITIS</drugindication>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>HYPEN</medicinalproduct>
      <drugstructuredosagenumb>400</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugseparatedosagenumb>1</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>804</drugintervaldosagedefinition>
      <drugdosageform>Tablet</drugdosageform>
      <drugadministrationroute>048</drugadministrationroute>
      <drugindication>RHEUMATOID ARTHRITIS</drugindication>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>BONALON</medicinalproduct>
      <drugstructuredosagenumb>35</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugseparatedosagenumb>1</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>803</drugintervaldosagedefinition>
      <drugdosageform>Tablet</drugdosageform>
      <drugadministrationroute>048</drugadministrationroute>
      <drugindication>OSTEOPOROSIS</drugindication>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>VOLTAREN</medicinalproduct>
      <drugdosagetext>SINGLE USE, DOSAGE DURING A DAY: 25 MG</drugdosagetext>
      <drugdosageform>Suppository</drugdosageform>
      <drugadministrationroute>054</drugadministrationroute>
      <drugindication>RHEUMATOID ARTHRITIS</drugindication>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>HALCION</medicinalproduct>
      <drugseparatedosagenumb>1</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>804</drugintervaldosagedefinition>
      <drugdosagetext>AS NEEDED 0.25 MG A DAY</drugdosagetext>
      <drugdosageform>Tablet</drugdosageform>
      <drugadministrationroute>048</drugadministrationroute>
      <drugindication>INSOMNIA</drugindication>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>PARIET</medicinalproduct>
      <drugstructuredosagenumb>10</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugseparatedosagenumb>1</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>804</drugintervaldosagedefinition>
      <drugdosageform>Tablet</drugdosageform>
      <drugadministrationroute>048</drugadministrationroute>
      <drugindication>GASTRITIS</drugindication>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>FOLIAMIN</medicinalproduct>
      <drugstructuredosagenumb>5</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugseparatedosagenumb>1</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>803</drugintervaldosagedefinition>
      <drugdosageform>Tablet</drugdosageform>
      <drugadministrationroute>048</drugadministrationroute>
      <drugindication>PROPHYLAXIS</drugindication>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20090730</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20100113</drugenddate>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>SULFAMETHOXAZOLE/TRIMETHOPRIM</medicinalproduct>
      <drugstructuredosagenumb>4</drugstructuredosagenumb>
      <drugstructuredosageunit>032</drugstructuredosageunit>
      <drugseparatedosagenumb>1</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>803</drugintervaldosagedefinition>
      <drugdosageform>Tablet</drugdosageform>
      <drugadministrationroute>048</drugadministrationroute>
      <drugindication>PROPHYLAXIS</drugindication>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20090730</drugstartdate>
      <drugenddateformat>102</drugenddateformat>
      <drugenddate>20100113</drugenddate>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>DEPAS</medicinalproduct>
      <drugstructuredosagenumb>.5</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugseparatedosagenumb>1</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>804</drugintervaldosagedefinition>
      <drugadministrationroute>048</drugadministrationroute>
    </drug>
  </patient>
</safetyreport>
<safetyreport>
  <safetyreportversion>3</safetyreportversion>
  <safetyreportid>7668475</safetyreportid>
  <primarysourcecountry>US</primarysourcecountry>
  <occurcountry>US</occurcountry>
  <transmissiondateformat>102</transmissiondateformat>
  <transmissiondate>20130627</transmissiondate>
  <serious>2</serious>
  <receivedateformat>102</receivedateformat>
  <receivedate>20101115</receivedate>
  <receiptdateformat>102</receiptdateformat>
  <receiptdate>20121205</receiptdate>
  <fulfillexpeditecriteria>2</fulfillexpeditecriteria>
  <companynumb>US-BIOGENIDEC-2010BI039480</companynumb>
  <duplicate>1</duplicate>
  <reportduplicate>
    <duplicatesource>BIOGEN</duplicatesource>
    <duplicatenumb>US-BIOGENIDEC-2010BI039480</duplicatenumb>
  </reportduplicate>
  <primarysource>
    <reportercountry>US</reportercountry>
    <qualification>5</qualification>
  </primarysource>
  <sender>
    <sendertype>2</sendertype>
    <senderorganization>FDA-Public Use </senderorganization>
  </sender>
  <receiver>
    <receivertype>6</receivertype>
    <receiverorganization>FDA</receiverorganization>
  </receiver>
  <patient>
    <patientonsetage>60.36</patientonsetage>
    <patientonsetageunit>801</patientonsetageunit>
    <patientsex>2</patientsex>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Lung disorder</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Pneumonia</reactionmeddrapt>
      <reactionoutcome>1</reactionoutcome>
    </reaction>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>TYSABRI</medicinalproduct>
      <drugauthorizationnumb>125104</drugauthorizationnumb>
      <drugstructuredosagenumb>300</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugseparatedosagenumb>1</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>802</drugintervaldosagedefinition>
      <drugdosageform>Intravenous infusion</drugdosageform>
      <drugadministrationroute>042</drugadministrationroute>
      <drugindication>MULTIPLE SCLEROSIS</drugindication>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20060722</drugstartdate>
      <actiondrug>4</actiondrug>
    </drug>
  </patient>
</safetyreport>
<safetyreport>
  <safetyreportversion>2</safetyreportversion>
  <safetyreportid>7757074</safetyreportid>
  <primarysourcecountry>NL</primarysourcecountry>
  <occurcountry>NL</occurcountry>
  <transmissiondateformat>102</transmissiondateformat>
  <transmissiondate>20130627</transmissiondate>
  <serious>1</serious>
  <seriousnessother>1</seriousnessother>
  <receivedateformat>102</receivedateformat>
  <receivedate>20110112</receivedate>
  <receiptdateformat>102</receiptdateformat>
  <receiptdate>20121022</receiptdate>
  <fulfillexpeditecriteria>1</fulfillexpeditecriteria>
  <companynumb>NL-ROCHE-751703</companynumb>
  <duplicate>1</duplicate>
  <reportduplicate>
    <duplicatesource>ROCHE</duplicatesource>
    <duplicatenumb>NL-ROCHE-751703</duplicatenumb>
  </reportduplicate>
  <primarysource>
    <reportercountry>COUNTRY NOT SPECIFIED</reportercountry>
    <qualification>3</qualification>
  </primarysource>
  <sender>
    <sendertype>2</sendertype>
    <senderorganization>FDA-Public Use </senderorganization>
  </sender>
  <receiver>
    <receivertype>6</receivertype>
    <receiverorganization>FDA</receiverorganization>
  </receiver>
  <patient>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Palmar-plantar erythrodysaesthesia syndrome</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Fatigue</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Thrombocytopenia</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Gamma-glutamyltransferase increased</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Blood alkaline phosphatase increased</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Alanine aminotransferase increased</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Blood bilirubin increased</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Hypertriglyceridaemia</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Nausea</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>CAPECITABINE</medicinalproduct>
      <drugauthorizationnumb>20-896</drugauthorizationnumb>
      <drugdosagetext>SINGLE DOSE 7 DAYS PRIOR TO START OF TREATMENT.</drugdosagetext>
      <drugdosageform>Tablet</drugdosageform>
      <drugadministrationroute>048</drugadministrationroute>
      <drugindication>NEOPLASM MALIGNANT</drugindication>
      <actiondrug>5</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>CAPECITABINE</medicinalproduct>
      <drugauthorizationnumb>20-896</drugauthorizationnumb>
      <drugseparatedosagenumb>2</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>804</drugintervaldosagedefinition>
      <drugdosagetext>STARTED FROM DAY 8, TWICE DAILY FOR 14 DAYS IN A 3 WEEK CYCLE.</drugdosagetext>
      <drugdosageform>Tablet</drugdosageform>
      <drugadministrationroute>048</drugadministrationroute>
      <actiondrug>5</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>EVEROLIMUS</medicinalproduct>
      <drugstructuredosagenumb>5</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugseparatedosagenumb>2</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>804</drugintervaldosagedefinition>
      <drugadministrationroute>048</drugadministrationroute>
      <drugindication>NEOPLASM MALIGNANT</drugindication>
      <actiondrug>5</actiondrug>
    </drug>
  </patient>
</safetyreport>
<safetyreport>
  <safetyreportversion>3</safetyreportversion>
  <safetyreportid>7735661</safetyreportid>
  <primarysourcecountry>US</primarysourcecountry>
  <occurcountry>US</occurcountry>
  <transmissiondateformat>102</transmissiondateformat>
  <transmissiondate>20130627</transmissiondate>
  <serious>1</serious>
  <seriousnessother>1</seriousnessother>
  <receivedateformat>102</receivedateformat>
  <receivedate>20101223</receivedate>
  <receiptdateformat>102</receiptdateformat>
  <receiptdate>20120906</receiptdate>
  <fulfillexpeditecriteria>1</fulfillexpeditecriteria>
  <companynumb>US-AMGEN-TCS435062</companynumb>
  <duplicate>1</duplicate>
  <reportduplicate>
    <duplicatesource>BAYER</duplicatesource>
    <duplicatenumb>US-AMGEN-TCS435062</duplicatenumb>
  </reportduplicate>
  <primarysource>
    <reportercountry>US</reportercountry>
    <qualification>5</qualification>
  </primarysource>
  <sender>
    <sendertype>2</sendertype>
    <senderorganization>FDA-Public Use </senderorganization>
  </sender>
  <receiver>
    <receivertype>6</receivertype>
    <receiverorganization>FDA</receiverorganization>
  </receiver>
  <patient>
    <patientonsetage>86.81</patientonsetage>
    <patientonsetageunit>801</patientonsetageunit>
    <patientweight>54.88</patientweight>
    <patientsex>2</patientsex>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Lung neoplasm malignant</reactionmeddrapt>
      <reactionoutcome>3</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Glomerular filtration rate decreased</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Injection site erythema</reactionmeddrapt>
      <reactionoutcome>3</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Injection site pruritus</reactionmeddrapt>
      <reactionoutcome>3</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Injection site warmth</reactionmeddrapt>
      <reactionoutcome>3</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Injection site pain</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ENBREL</medicinalproduct>
      <drugbatchnumb> 1025530</drugbatchnumb>
      <drugauthorizationnumb>103-795</drugauthorizationnumb>
      <drugstructuredosagenumb>50</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugseparatedosagenumb>1</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>803</drugintervaldosagedefinition>
      <drugdosagetext>50 mg, qwk</drugdosagetext>
      <drugdosageform>Solution for injection in pre-filled syringe</drugdosageform>
      <drugadministrationroute>058</drugadministrationroute>
      <drugindication>RHEUMATOID ARTHRITIS</drugindication>
      <drugstartdateformat>610</drugstartdateformat>
      <drugstartdate>201112</drugstartdate>
      <actiondrug>1</actiondrug>
      <drugrecurreadministration>3</drugrecurreadministration>
    </drug>
  </patient>
</safetyreport>
<safetyreport>
  <safetyreportversion>2</safetyreportversion>
  <safetyreportid>7759266</safetyreportid>
  <primarysourcecountry>US</primarysourcecountry>
  <occurcountry>US</occurcountry>
  <transmissiondateformat>102</transmissiondateformat>
  <transmissiondate>20130627</transmissiondate>
  <serious>2</serious>
  <receivedateformat>102</receivedateformat>
  <receivedate>20110113</receivedate>
  <receiptdateformat>102</receiptdateformat>
  <receiptdate>20120913</receiptdate>
  <fulfillexpeditecriteria>2</fulfillexpeditecriteria>
  <companynumb>US-PFIZER INC-2011003042</companynumb>
  <duplicate>1</duplicate>
  <reportduplicate>
    <duplicatesource>PFIZER</duplicatesource>
    <duplicatenumb>US-PFIZER INC-2011003042</duplicatenumb>
  </reportduplicate>
  <primarysource>
    <reportercountry>US</reportercountry>
    <qualification>5</qualification>
  </primarysource>
  <sender>
    <sendertype>2</sendertype>
    <senderorganization>FDA-Public Use </senderorganization>
  </sender>
  <receiver>
    <receivertype>6</receivertype>
    <receiverorganization>FDA</receiverorganization>
  </receiver>
  <patient>
    <patientsex>1</patientsex>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Malaise</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Memory impairment</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>PRISTIQ</medicinalproduct>
      <drugauthorizationnumb>21-992</drugauthorizationnumb>
      <drugstructuredosagenumb>50</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugdosagetext>50 mg, UNK</drugdosagetext>
      <drugdosageform>Prolonged-release tablet</drugdosageform>
      <actiondrug>5</actiondrug>
    </drug>
  </patient>
</safetyreport>
<safetyreport>
  <safetyreportversion>2</safetyreportversion>
  <safetyreportid>7673651</safetyreportid>
  <primarysourcecountry>US</primarysourcecountry>
  <occurcountry>US</occurcountry>
  <transmissiondateformat>102</transmissiondateformat>
  <transmissiondate>20130627</transmissiondate>
  <serious>1</serious>
  <seriousnesshospitalization>1</seriousnesshospitalization>
  <seriousnessother>1</seriousnessother>
  <receivedateformat>102</receivedateformat>
  <receivedate>20101118</receivedate>
  <receiptdateformat>102</receiptdateformat>
  <receiptdate>20121029</receiptdate>
  <fulfillexpeditecriteria>1</fulfillexpeditecriteria>
  <companynumb>US-BAYER-201041613NA</companynumb>
  <duplicate>1</duplicate>
  <reportduplicate>
    <duplicatesource>BAYER</duplicatesource>
    <duplicatenumb>US-BAYER-201041613NA</duplicatenumb>
  </reportduplicate>
  <primarysource>
    <reportercountry>US</reportercountry>
    <qualification>5</qualification>
  </primarysource>
  <sender>
    <sendertype>2</sendertype>
    <senderorganization>FDA-Public Use </senderorganization>
  </sender>
  <receiver>
    <receivertype>6</receivertype>
    <receiverorganization>FDA</receiverorganization>
  </receiver>
  <patient>
    <patientonsetage>38</patientonsetage>
    <patientonsetageunit>801</patientonsetageunit>
    <patientweight>86.17</patientweight>
    <patientsex>2</patientsex>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Pulmonary embolism</reactionmeddrapt>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Gallbladder non-functioning</reactionmeddrapt>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Deep vein thrombosis</reactionmeddrapt>
    </reaction>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>YAZ</medicinalproduct>
      <drugauthorizationnumb>021676</drugauthorizationnumb>
      <drugdosageform>Film-coated tablet</drugdosageform>
      <drugadministrationroute>048</drugadministrationroute>
      <drugindication>BIRTH CONTROL</drugindication>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>YASMIN</medicinalproduct>
      <drugdosageform>Film-coated tablet</drugdosageform>
      <drugadministrationroute>048</drugadministrationroute>
      <drugindication>PRODUCT USED FOR UNKNOWN INDICATION</drugindication>
    </drug>
  </patient>
</safetyreport>
<safetyreport>
  <safetyreportversion>2</safetyreportversion>
  <safetyreportid>7737677</safetyreportid>
  <primarysourcecountry>US</primarysourcecountry>
  <occurcountry>US</occurcountry>
  <transmissiondateformat>102</transmissiondateformat>
  <transmissiondate>20130627</transmissiondate>
  <serious>2</serious>
  <receivedateformat>102</receivedateformat>
  <receivedate>20101223</receivedate>
  <receiptdateformat>102</receiptdateformat>
  <receiptdate>20121023</receiptdate>
  <fulfillexpeditecriteria>2</fulfillexpeditecriteria>
  <companynumb>US-AMGEN-KDL441867</companynumb>
  <duplicate>1</duplicate>
  <reportduplicate>
    <duplicatesource>AMGEN</duplicatesource>
    <duplicatenumb>US-AMGEN-KDL441867</duplicatenumb>
  </reportduplicate>
  <primarysource>
    <reportercountry>US</reportercountry>
    <qualification>5</qualification>
  </primarysource>
  <sender>
    <sendertype>2</sendertype>
    <senderorganization>FDA-Public Use </senderorganization>
  </sender>
  <receiver>
    <receivertype>6</receivertype>
    <receiverorganization>FDA</receiverorganization>
  </receiver>
  <patient>
    <patientonsetage>59</patientonsetage>
    <patientonsetageunit>801</patientonsetageunit>
    <patientweight>90.7</patientweight>
    <patientsex>2</patientsex>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Hot flush</reactionmeddrapt>
      <reactionoutcome>3</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Hyperhidrosis</reactionmeddrapt>
      <reactionoutcome>3</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>White blood cell count increased</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Neutrophil count increased</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Blood glucose increased</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Protein total decreased</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Blood bilirubin increased</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Globulins decreased</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Injection site pain</reactionmeddrapt>
      <reactionoutcome>3</reactionoutcome>
    </reaction>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ENBREL</medicinalproduct>
      <drugbatchnumb> 1020934</drugbatchnumb>
      <drugauthorizationnumb>103-795</drugauthorizationnumb>
      <drugstructuredosagenumb>50</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugseparatedosagenumb>1</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>803</drugintervaldosagedefinition>
      <drugdosagetext>50 mg, qwk</drugdosagetext>
      <drugdosageform>Unknown formulation</drugdosageform>
      <drugadministrationroute>058</drugadministrationroute>
      <drugindication>RHEUMATOID ARTHRITIS</drugindication>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20080120</drugstartdate>
      <actiondrug>5</actiondrug>
      <drugrecurreadministration>3</drugrecurreadministration>
    </drug>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>ENBREL</medicinalproduct>
      <drugauthorizationnumb>103-795</drugauthorizationnumb>
      <drugstructuredosagenumb>50</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugseparatedosagenumb>1</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>803</drugintervaldosagedefinition>
      <drugdosagetext>50 mg, qwk</drugdosagetext>
      <drugdosageform>Unknown formulation</drugdosageform>
      <drugadministrationroute>058</drugadministrationroute>
      <drugstartdateformat>610</drugstartdateformat>
      <drugstartdate>200904</drugstartdate>
      <actiondrug>5</actiondrug>
      <drugrecurreadministration>3</drugrecurreadministration>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>METHOTREXATE</medicinalproduct>
      <drugstructuredosagenumb>2.5</drugstructuredosagenumb>
      <drugstructuredosageunit>003</drugstructuredosageunit>
      <drugseparatedosagenumb>1</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>803</drugintervaldosagedefinition>
      <drugdosagetext>2.5 mg, qwk</drugdosagetext>
      <drugdosageform>Tablet</drugdosageform>
      <drugadministrationroute>048</drugadministrationroute>
    </drug>
  </patient>
</safetyreport>
<safetyreport>
  <safetyreportversion>5</safetyreportversion>
  <safetyreportid>7676422</safetyreportid>
  <primarysourcecountry>US</primarysourcecountry>
  <occurcountry>US</occurcountry>
  <transmissiondateformat>102</transmissiondateformat>
  <transmissiondate>20130627</transmissiondate>
  <serious>1</serious>
  <seriousnesshospitalization>1</seriousnesshospitalization>
  <seriousnessother>1</seriousnessother>
  <receivedateformat>102</receivedateformat>
  <receivedate>20101119</receivedate>
  <receiptdateformat>102</receiptdateformat>
  <receiptdate>20121019</receiptdate>
  <fulfillexpeditecriteria>1</fulfillexpeditecriteria>
  <companynumb>US-US-EMD SERONO, INC.-7027503</companynumb>
  <duplicate>1</duplicate>
  <reportduplicate>
    <duplicatesource>EMD SERONO INC</duplicatesource>
    <duplicatenumb>US-US-EMD SERONO, INC.-7027503</duplicatenumb>
  </reportduplicate>
  <primarysource>
    <reportercountry>US</reportercountry>
    <qualification>3</qualification>
  </primarysource>
  <sender>
    <sendertype>2</sendertype>
    <senderorganization>FDA-Public Use </senderorganization>
  </sender>
  <receiver>
    <receivertype>6</receivertype>
    <receiverorganization>FDA</receiverorganization>
  </receiver>
  <patient>
    <patientonsetage>43.33</patientonsetage>
    <patientweight>53</patientweight>
    <patientsex>2</patientsex>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Sarcoidosis</reactionmeddrapt>
      <reactionoutcome>2</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Haemorrhage</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Post procedural haemorrhage</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Migraine</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Pyrexia</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Sinusitis</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Blood potassium decreased</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Feeling abnormal</reactionmeddrapt>
      <reactionoutcome>3</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Constipation</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Multiple sclerosis</reactionmeddrapt>
      <reactionoutcome>6</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Fatigue</reactionmeddrapt>
      <reactionoutcome>3</reactionoutcome>
    </reaction>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>REBIF</medicinalproduct>
      <drugbatchnumb> Y1781767,AU002242</drugbatchnumb>
      <drugauthorizationnumb>103780</drugauthorizationnumb>
      <drugstructuredosagenumb>22</drugstructuredosagenumb>
      <drugstructuredosageunit>004</drugstructuredosageunit>
      <drugseparatedosagenumb>3</drugseparatedosagenumb>
      <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
      <drugintervaldosagedefinition>803</drugintervaldosagedefinition>
      <drugdosageform>Injection</drugdosageform>
      <drugadministrationroute>058</drugadministrationroute>
      <drugindication>MULTIPLE SCLEROSIS</drugindication>
      <drugstartdateformat>102</drugstartdateformat>
      <drugstartdate>20030401</drugstartdate>
      <drugenddateformat>610</drugenddateformat>
      <drugenddate>201208</drugenddate>
      <actiondrug>4</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>GABAPENTIN</medicinalproduct>
      <drugindication>PAIN</drugindication>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>IMITREX</medicinalproduct>
      <drugindication>MIGRAINE</drugindication>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>PROTONIX</medicinalproduct>
      <drugindication>GASTROOESOPHAGEAL REFLUX DISEASE</drugindication>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>CALCIUM WITH VITAMIN D</medicinalproduct>
      <drugindication>SUPPLEMENTATION THERAPY</drugindication>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>OXYCODONE</medicinalproduct>
      <drugindication>PAIN</drugindication>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>CLONAZEPAM</medicinalproduct>
      <drugindication>INSOMNIA</drugindication>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>MOTRIN</medicinalproduct>
      <drugindication>PREMEDICATION</drugindication>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>PROMETHAZINE</medicinalproduct>
      <drugindication>PRODUCT USED FOR UNKNOWN INDICATION</drugindication>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>VITAMIIN D</medicinalproduct>
      <drugindication>SUPPLEMENTATION THERAPY</drugindication>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>MELATONIN</medicinalproduct>
      <drugindication>SLEEP DISORDER</drugindication>
    </drug>
  </patient>
</safetyreport>
<safetyreport>
  <safetyreportversion>7</safetyreportversion>
  <safetyreportid>7798049</safetyreportid>
  <primarysourcecountry>JP</primarysourcecountry>
  <occurcountry>JP</occurcountry>
  <transmissiondateformat>102</transmissiondateformat>
  <transmissiondate>20130627</transmissiondate>
  <serious>1</serious>
  <seriousnesslifethreatening>1</seriousnesslifethreatening>
  <seriousnesshospitalization>1</seriousnesshospitalization>
  <receivedateformat>102</receivedateformat>
  <receivedate>20110203</receivedate>
  <receiptdateformat>102</receiptdateformat>
  <receiptdate>20121228</receiptdate>
  <fulfillexpeditecriteria>1</fulfillexpeditecriteria>
  <companynumb>JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2011-DE-00746GD</companynumb>
  <duplicate>1</duplicate>
  <reportduplicate>
    <duplicatesource>BOEHRINGER INGELHEIM</duplicatesource>
    <duplicatenumb>JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2011-DE-00746GD</duplicatenumb>
  </reportduplicate>
  <primarysource>
    <reportercountry>COUNTRY NOT SPECIFIED</reportercountry>
    <qualification>3</qualification>
  </primarysource>
  <sender>
    <sendertype>2</sendertype>
    <senderorganization>FDA-Public Use </senderorganization>
  </sender>
  <receiver>
    <receivertype>6</receivertype>
    <receiverorganization>FDA</receiverorganization>
  </receiver>
  <patient>
    <patientsex>1</patientsex>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Intestinal stenosis</reactionmeddrapt>
      <reactionoutcome>3</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Haematochezia</reactionmeddrapt>
      <reactionoutcome>3</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Anaemia</reactionmeddrapt>
      <reactionoutcome>3</reactionoutcome>
    </reaction>
    <reaction>
      <reactionmeddraversionpt>16.0</reactionmeddraversionpt>
      <reactionmeddrapt>Bladder cancer</reactionmeddrapt>
      <reactionoutcome>3</reactionoutcome>
    </reaction>
    <drug>
      <drugcharacterization>1</drugcharacterization>
      <medicinalproduct>MOBIC</medicinalproduct>
      <drugauthorizationnumb>20-938</drugauthorizationnumb>
      <drugdosagetext>10 mg</drugdosagetext>
      <drugdosageform>Tablet</drugdosageform>
      <drugadministrationroute>048</drugadministrationroute>
      <drugindication>BACK PAIN</drugindication>
      <drugstartdateformat>602</drugstartdateformat>
      <drugstartdate>2000</drugstartdate>
      <actiondrug>1</actiondrug>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>BUP-4</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>PANTOSIN</medicinalproduct>
    </drug>
    <drug>
      <drugcharacterization>2</drugcharacterization>
      <medicinalproduct>MAGNESIUM OXIDE</medicinalproduct>
    </drug>
  </patient>
</safetyreport>
</ichicsr>